CSIMC Recommends NHI Price Listing for 15 APIs/20 Products

At a general meeting on September 7, the Central Social Insurance Medical Council (CSIMC; Chuikyo) recommended NHI price listing for 15 APIs (active pharmaceutical ingredients)/20 products, including AstraZeneca’s proton pump inhibitor (PPI) Nexium capsule 10 mg and 20 mg (esomeprazole magnesium) and Astellas Pharma’s treatment for overactive bladder Betanis Tablet 25 mg and 50 mg (mirabegron). The adrenal hormone preparation EpiPen Injection 0.15 mg and 0.3 mg (adrenaline) will be added to the NHI price list on September 22. Other products will be included in the NHI price list on September 12.
> Read full story


1 Year after Viagra Generic Debut, Freely Priced Generics Seem to Be Bringing Benefits


Japan Agency for Medical Research and Development (AMED):

The Column

“Every Search Is Won Before It’s Ever Fought”: Sun Tzu


180 Billion Yen Sales in FY2017 Is “Quite Reachable”: Meiji Seika Pharma President(May.22)
Top-4 Japanese Drug Makers Report Widely Different Financial Results for FY2014(May.22)
Oncologics Retain Top Position in Therapeutic Category Sales Ranking in FY2014: IMS(May.22)
Japan Pharma Market Down by 0.6% to Under 10 Trillion Yen in FY2014: IMS(May.22)
“Every Search Is Won Before It’s Ever Fought”: Sun Tzu(May.22)

Most Read

Japan’s Biosimilar Market to Rise to 31....
Chuikyo Reps Discuss HTA, Re-Pricing as ...
MHLW Announces 196 Newly Designated Intr...
PAFSC Second Committee to Discuss Gilead...
Chuikyo Approves Listing of 5 Drugs with...

News Calendar